Skip to main content

Mitral Inflow E/A Ratio in Echocardiography


Mitral Inflow E/A Ratio in Echocardiography: Measurement, Interpretation and Clinical Significance

The mitral inflow E/A ratio is one of the fundamental parameters used in echocardiography to assess left ventricular (LV) diastolic function. It provides valuable information about ventricular relaxation, early diastolic filling and the contribution of atrial contraction to ventricular filling.

Measured using pulsed-wave Doppler across the mitral valve, the E/A ratio is an essential component of the comprehensive assessment of diastolic function. However, its interpretation requires consideration of patient age, heart rate, loading conditions and other echocardiographic parameters.

1. What Is the Mitral Inflow E/A Ratio?

During diastole, blood flows from the left atrium (LA) into the left ventricle (LV) through the mitral valve. This process produces two characteristic Doppler waves:

  • E wave (Early filling wave): Represents early passive filling of the left ventricle following mitral valve opening. It is mainly influenced by LV relaxation and the pressure gradient between the left atrium and left ventricle.
  • A wave (Atrial contraction wave): Represents active LV filling resulting from left atrial contraction during late diastole.

The E/A ratio is calculated by dividing the peak early diastolic transmitral velocity by the peak late diastolic transmitral velocity.

E/A Ratio Formula

E/A = Peak E velocity / Peak A velocity

Both velocities are measured in m/s or cm/s.

2. How to Measure the E/A Ratio?

Mitral inflow velocities are obtained using pulsed-wave Doppler during transthoracic echocardiography.

Step-by-Step Acquisition Technique

  1. Obtain the apical four-chamber view: Optimize the view to visualize the mitral valve and left ventricular inflow.
  2. Activate pulsed-wave Doppler: Position the Doppler sample volume at the tips of the mitral valve leaflets during diastole.
  3. Optimize alignment: Align the Doppler beam as parallel as possible to the direction of transmitral blood flow.
  4. Adjust the Doppler settings: Optimize gain, scale and baseline to obtain a clear spectral Doppler envelope.
  5. Record the waveform: Identify the early diastolic E wave and late diastolic A wave.
  6. Measure peak velocities: Measure the highest velocity of each wave using the outer edge of the spectral envelope.
  7. Calculate the ratio: Divide peak E velocity by peak A velocity.
Practical Tip: The sample volume should be positioned at the mitral leaflet tips, rather than too close to the mitral annulus or deep inside the left ventricle. Incorrect positioning may produce inaccurate transmitral velocities.

3. Understanding the E and A Waves

E Wave – Early Diastolic Filling

The E wave occurs immediately after the mitral valve opens. It reflects early rapid filling of the left ventricle, driven by the pressure gradient between the left atrium and left ventricle.

Its velocity is influenced by:

  • LV myocardial relaxation.
  • Left atrial pressure.
  • LV compliance and stiffness.
  • Preload and volume status.

A Wave – Atrial Contraction

The A wave occurs during atrial systole and represents the additional blood entering the left ventricle following atrial contraction.

Its velocity is influenced by:

  • Left atrial contractility.
  • LV compliance.
  • LV end-diastolic pressure.
  • Preload and heart rate.

The relative heights of these two waves provide useful information about the pattern of LV filling.

4. Interpretation of the E/A Ratio

The E/A ratio changes with age and the progression of diastolic dysfunction. Traditionally, three characteristic transmitral filling patterns are described.

A. Normal Filling Pattern

  • E wave is generally higher than the A wave.
  • E/A ratio is usually greater than 1 in healthy younger and middle-aged adults.
  • Early LV relaxation and filling are relatively preserved.

Normal values vary with age. A ratio that is considered normal in a young adult may not be appropriate for an older individual.

B. Impaired Relaxation Pattern – Grade I

  • Reduced early diastolic E wave velocity.
  • Increased contribution of atrial contraction to LV filling.
  • A wave becomes relatively higher than the E wave.
  • E/A ratio is typically reduced, often below 0.8.
  • Deceleration time is often prolonged.

This pattern commonly occurs with aging, hypertension, LV hypertrophy and other conditions associated with impaired myocardial relaxation.

C. Pseudonormal Filling Pattern – Traditionally Grade II

With progression of diastolic dysfunction, left atrial pressure may increase. This elevated pressure increases early transmitral flow and can restore the E/A ratio to an apparently normal range.

  • E wave increases compared with the impaired relaxation pattern.
  • A wave may remain relatively prominent.
  • E/A ratio may fall within an apparently normal range.
  • Elevated left atrial pressure may be present despite an apparently normal transmitral filling pattern.

This is known as pseudonormalization. Additional parameters, including tissue Doppler e', E/e', tricuspid regurgitation velocity and left atrial assessment, are needed to avoid misclassification.

D. Restrictive Filling Pattern – Traditionally Grade III

  • Markedly increased E wave velocity.
  • Relatively reduced A wave velocity.
  • E/A ratio is typically 2 or greater.
  • Deceleration time is often shortened.

This pattern is associated with significantly elevated left atrial pressure and restrictive LV filling physiology. Clinical context and other echocardiographic findings are essential for interpretation.

5. Summary of Mitral Inflow Patterns

Parameter Impaired Relaxation Pseudonormal Restrictive
E wave Reduced Increased compared with impaired relaxation Markedly increased
A wave Prominent Variable Relatively reduced
E/A ratio Usually ≤0.8 Usually 0.8–2 Usually ≥2
Deceleration time Prolonged Variable Shortened

Note: These are traditional descriptive patterns, not a stand-alone grading algorithm. The 2025 ASE recommendations require a comprehensive, integrated assessment rather than assigning diastolic dysfunction grade from the E/A ratio alone.

6. Important Factors Affecting the E/A Ratio

Several physiological and pathological factors can alter transmitral filling velocities.

  • Age: E/A ratio normally decreases with advancing age because of changes in LV relaxation.
  • Heart rate: Tachycardia may cause E and A wave fusion, making accurate measurement difficult.
  • Preload: Changes in circulating blood volume can alter E wave velocity.
  • Atrial fibrillation: The absence of organized atrial contraction means a conventional E/A ratio cannot be calculated.
  • Mitral valve disease: Mitral stenosis, significant mitral regurgitation and mitral annular calcification may affect transmitral flow.
  • AV conduction abnormalities: Altered timing between atrial contraction and ventricular relaxation may change the Doppler waveform.
  • LV systolic function: Changes in LV function can influence filling dynamics and loading conditions.

7. Role of E/A Ratio in the 2025 ASE Diastolic Function Guidelines

The American Society of Echocardiography published updated recommendations for the evaluation of LV diastolic function in July 2025.

The updated recommendations emphasize an integrated approach to diastolic function and left atrial pressure assessment. Mitral inflow remains important, but the E/A ratio should not be interpreted in isolation.

Important echocardiographic parameters include:

  1. Mitral annular e' velocity: Assesses myocardial relaxation using tissue Doppler imaging.
  2. E/e' ratio: Provides an estimate of LV filling pressure.
  3. Tricuspid regurgitation velocity or pulmonary artery systolic pressure: Helps assess pulmonary pressure elevation.
  4. Mitral inflow E/A ratio: Provides information about the relative contribution of early and late diastolic filling.
  5. Left atrial reservoir strain: Provides additional information about left atrial function when available.
  6. Pulmonary venous Doppler: May provide supplementary information in selected patients.

The 2025 ASE guideline uses a multiparametric approach, incorporating myocardial relaxation and estimates of filling pressure. Additional measurements are used when the primary parameters are discordant or inconclusive.

Clinical Take-Home Message

A normal E/A ratio does not necessarily indicate normal diastolic function. Pseudonormalization can occur in patients with elevated left atrial pressure. Always interpret transmitral Doppler alongside tissue Doppler and other relevant echocardiographic findings.

8. Common Pitfalls During Measurement

  • Incorrect sample volume placement away from the mitral leaflet tips.
  • Poor Doppler alignment with transmitral flow.
  • Excessive spectral Doppler gain, resulting in an unclear envelope.
  • Measuring incomplete or fused E and A waves.
  • Ignoring the effects of age and heart rate.
  • Using E/A ratio alone to diagnose or grade diastolic dysfunction.
  • Failing to recognize pseudonormal filling.

9. Clinical Example

Consider a patient with hypertension and LV hypertrophy undergoing transthoracic echocardiography.

Mitral inflow Doppler demonstrates:

  • Peak E velocity = 0.60 m/s
  • Peak A velocity = 0.90 m/s

Calculation:

E/A = 0.60 / 0.90 = 0.67

The reduced E/A ratio suggests an impaired relaxation pattern.

However, the final assessment of diastolic function requires additional parameters, including mitral annular e' velocity, E/e' ratio and other relevant measurements.

10. Key Points for Echocardiography Fellows and Sonographers

  • Always obtain mitral inflow Doppler from the apical four-chamber view.
  • Place the pulsed-wave Doppler sample volume at the mitral leaflet tips.
  • E wave represents early passive ventricular filling.
  • A wave represents atrial contraction.
  • E/A ratio is calculated by dividing peak E velocity by peak A velocity.
  • Age has a significant influence on the normal E/A ratio.
  • Pseudonormalization can mask underlying diastolic dysfunction.
  • Never diagnose or grade diastolic dysfunction using E/A ratio alone.
  • Use the latest ASE recommendations for comprehensive assessment.

References

  1. Nagueh SF, Sanborn DY, Oh JK, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography and for Heart Failure With Preserved Ejection Fraction Diagnosis: An Update From the American Society of Echocardiography. J Am Soc Echocardiogr. 2025;38(7):537–569. doi:10.1016/j.echo.2025.03.011. PubMed.
  2. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29:277–314. Full guideline.

drmusmanjaved.com

Practical Echocardiography | Cardiology Education | Clinical Skills

Comments

Popular posts from this blog

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

2025 ESC Guidelines on INR Targets in Mechanical Valves

  2025 ESC Guidelines on INR Targets in Mechanical Valves INR Targets in Patients With Mechanical Heart Valves Updated, guideline-oriented review Mechanical heart valves are inherently thrombogenic and require lifelong anticoagulation. Vitamin K antagonists, particularly warfarin, remain the standard therapy. The international normalized ratio (INR) is used to guide anticoagulation intensity and must be individualized based on valve type, valve position, and patient-related thromboembolic risk factors. Subtherapeutic INR increases the risk of valve thrombosis and systemic embolism, whereas excessive anticoagulation increases bleeding risk. Why INR control is critical Mechanical valves promote thrombosis due to non-physiological blood flow, high shear stress, and continuous contact between blood and artificial surfaces. These prothrombotic mechanisms persist for life. Direct oral anticoagulants are contraindicated in mechanical valves; therefore, VKAs remain mandatory. The goal of I...